Enterline & Partners Consulting | info@enterlinepartners.com

Potential Waivers for COVID-19 Vaccination Requirements for Immigrants

All immigrants to the U.S. must pass a medical examination prior to their visa interview. One of the criteria determined at the medical examination is whether the intending immigrant has received vaccinations required to be eligible to immigrate.

Beginning October 1, 2021, most immigrants will be required to receive a COVID-19 vaccination before receiving their immigrant visa. The U.S. Center for Disease Control and Prevention recognizes COVID-19 vaccines manufactured by Pfizer-BioNTech, Moderna, and Jannsen Johnson & Johnson and also those approved for emergency use by the World Health Organization: Oxford/AstraZeneca, Sinopharm and Sinovac (as of October 5, 2021)

As with most required vaccinations, there are waivers available for the COVID-19 vaccine if it is determined that the vaccine is not “medically appropriate”.

During the medical exam, if the vaccine is not medically appropriate, the examining doctor should indicate the reason on the Report of Medical Examination and Vaccination Record (Form I-693).  The United States Citizenship and Immigration Services (“USCIS”) will then waive the vaccine requirement for the immigrant. Unlike most other waivers for grounds of inadmissibility, a separate waiver application is not required for an officer to grant a waiver for the vaccination requirement.  This is referred to as a “blanket waiver’

Not “medically appropriate” reasons for a blanket waiver for the COVID-19 vaccination:

  • Not Age-Appropriate

For COVID-19 vaccines, the age at which a particular vaccine can be administered differs between vaccines. If the immigrant is younger than the lowest age limit for the approved COVID-19 vaccine, a blanket waiver may be available. Moreover, if there is an age restriction in the country, for example, the vaccine is only being given to people over the age of 65 and the immigrant is younger than 65, a waiver may be available.

  • Contraindication

If an immigrant has a known contraindication (negative reaction) or precaution to the COVID-19 vaccine that is available in the country, or if the immigrant has had a severe reaction to the first dose, a waiver may be available.

  • Not routinely available

If none of the approved COVID-19 vaccines are routinely available in the country where the immigrant is taking the medical examination, or if an approved COVID-19 vaccine is available to the immigrant but limited supply would cause significant delay for the immigrant to receive it, a waiver may be available.

  • Religious or moral convictions

If an immigrant objects to vaccination based on religious or moral beliefs, this will be documented on the immigrant’s medical examination form.  However, this is not a blanket waiver, and the immigrant must submit a waiver request to U.S. Citizenship and Immigration Services which will determine if the waiver is granted.

If you have questions about the new rules for COVID-19 vaccinations, you can contact us at info@enterlinepartners.com and speak with a U.S. immigration lawyer in Ho Chi Minh City, Manila and Taipei.

ENTERLINE & PARTNERS CONSULTING

Ho Chi Minh City, Vietnam Office

Suite 601, 6th Floor, Saigon Tower
29 Le Duan Street
Ben Nghe Ward, District 1
Ho Chi Minh City, Vietnam

Tel: +84 933 301 488

Email: info@enterlinepartners.com

Facebook: Enterline & Partners – Dịch vụ Thị thực và Định cư Hoa Kỳ

Website: http://enterlinepartners.com

Manila, Philippines Office

LKG Tower 37th Floor
6801 Ayala Avenue
Makati City, Philippines 1226

Tel: +632 5310 1491

Email: info@enterlinepartners.com

Facebook: Enterline and Partners Philippines

Website: https://enterlinepartners.com/language/en/welcome/

Copyright 2021. This article is for information purposes only and does not constitute legal advice. This article may be changed with or without notice. The opinions expressed in this article are those of Enterline and Partners only.

CATEGORY
time
recent posts
CTA_Collection

contact us today for more information

Latest News

Can I travel outside the U.S. and return after my I-829 is denied?

Traveling outside the United States after a Form I-829 Petition by Investor to Remove Conditions on Permanent Resident Status (“I-829 Petition”) denial is highly risky and strongly discouraged. While you, the investor and your family members, legally retain your Conditional Lawful Permanent Resident (“CPR”) status until a final administrative order of removal is issued by an immigration judge, U.S. Customs and Border Protection (“CBP”) enforces strict border policies, although improper, that can challenge your ability to return. Filing the I-829 Petition is the final step for investors in the U.S. EB-5 immigrant investor visa program.  An approval of the I-829 Petition removes the two-year conditional restrictions on an investor’s residency, granting lawful permanent resident status, and allowing the investor, their spouse, and unmarried children under 21 to receive a 10-year “Green Card”. The denial of the I-829 Petition does not immediately result in loss of an investor’s CPR status.  The

Read more >

Regional Center Job Creation under the RIA

When evaluating whether an EB-5 investment meets the requirement that an investor create at least 10 jobs for qualified U.S. workers, there is now more guidance under the RIA than before.  In general, an investment in a business sponsored by a Regional Center does not require all qualifying jobs come from employees hired directly by the business. Indirect and induced job creation based on approved methodologies remains the core of the Regional Center program advantage. As before the RIA, investors may rely on economically and statistically valid methodologies to determine the number of jobs attributable to the investment. These methodologies may be used to support estimates of directly created jobs and, where permitted under the statute, jobs created directly or indirectly through capital expenditures, increased export revenues, enhanced regional productivity, and broader domestic capital investment generated by the project. However, indirect job creation is now lightly restricted with only a

Read more >

David Enterline receives I-829 Petition award for 2025 from IIUSA

David Enterline, Managing Partner of Enterline and Partners Consulting was recognized by IIUSA, the preeminent EB-5 trade association in the United States, for successfully assisting EB-5 immigrant investor clients in obtaining approvals of Form I-829, Petition by Investor to Remove Conditions on Permanent Resident Status during the year 2025. David was recognized together with a select group of experienced EB-5 attorneys and Regional Centers that have demonstrated a strong record of successful outcomes for EB-5 investors. The recognition was presented during the 2026 IIUSA EB-5 Industry Forum held in Washington, District of Columbia. IIUSA (Invest in the USA) is the national membership-based trade association representing stakeholders in the EB-5 Regional Center Program. Its members are responsible for a significant portion of the investment capital and job creation generated across the United States through the EB-5 Program. IIUSA recognizes EB-5 attorneys and Regional Centers whose investors have successfully received I-829 Petition

Read more >
Zalo
Phone
WhatsApp
Messenger
Messenger
WhatsApp
Phone
Zalo